Does Medicaid cover weight-loss pills?
We may earn a commission from some links on this page. How we make money.
Why most states don't cover it
Federal Medicaid rules let each state decide whether to cover drugs used for weight loss. Because GLP-1 medications are expensive and demand is high, most states have chosen not to cover them for obesity. The same drug is often covered when it's prescribed for type 2 diabetes, because that's a separate, covered use.
So whether Medicaid pays usually comes down to two things: your state, and the diagnosis your medication is prescribed for.
Where Medicaid covers GLP-1s for weight loss
According to KFF's state survey, these 13 states covered GLP-1 drugs for obesity under Medicaid fee-for-service as of January 2026:
Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Rhode Island, Tennessee, Utah, Virginia and Wisconsin.
Even in these states, coverage comes with strings: prior authorization, a BMI threshold, and often a documented attempt at diet-and-lifestyle change first. Managed-care plans within a state can also apply their own rules.
What this means for the pills
The two FDA-approved weight-loss pills — the Wegovy pill (oral semaglutide) and Foundayo (orforglipron) — are new, so even in covering states they may not be on the Medicaid formulary yet. If your state covers GLP-1s for obesity, ask specifically whether these pills are listed, or whether only the injectables are. For a side-by-side breakdown of the two pills, see our Wegovy pill vs. Foundayo comparison.
If your state says no, you still have options
- If you're also on Medicare: the Medicare GLP-1 Bridge can bring the Wegovy pill to $50 a month if you qualify — a separate program from Medicaid.
- Paying cash: both pills start at $149/month through the makers' own pharmacies. See where to get them.
- A diabetes diagnosis changes the picture: if you have type 2 diabetes, Medicaid in your state may already cover a GLP-1 for that — a conversation to have with your doctor.
Compounded GLP-1s are sometimes marketed as a cheaper route. They are not FDA-approved, and Medicaid does not cover them. Here's how compounded compares.
Check your own state
Medicaid rules change often, and your managed-care plan may differ from the state's base policy. The reliable way to confirm is to call the number on your Medicaid card or check your plan's drug list (formulary) for the specific medication name.
If Medicaid won't cover it
On Medicare too? The $50 GLP-1 Bridge may help. Paying cash, both pills start at $149/mo — compare on our where-to-get page.
FAQ
Does Medicaid cover Wegovy or the Wegovy pill for weight loss?
Only in some states. As of January 2026, 13 state Medicaid programs covered GLP-1 drugs for obesity. In the other states, Medicaid covers semaglutide only for approved conditions like type 2 diabetes, not for weight loss alone. Even where it's covered, expect prior authorization and a BMI requirement.
Which states cover GLP-1 weight-loss drugs under Medicaid?
Per KFF's January 2026 survey: Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Rhode Island, Tennessee, Utah, Virginia and Wisconsin. This list changes, and some states are considering dropping coverage, so confirm with your own plan.
Does Medicaid cover weight-loss pills if I have diabetes?
Often yes — but for the diabetes, not for weight loss. GLP-1 medications are widely covered by Medicaid when prescribed for type 2 diabetes. Your doctor prescribes based on your diagnosis.
Will Medicaid cover compounded semaglutide?
No. Compounded GLP-1s are not FDA-approved, and Medicaid does not cover them.
